Seol an Taifead seo mar Ríomhphost: A TISSUE BIOMARKER BASED MODEL THAT IDENTIFIES PATIENTS WITH A HIGH RISK OF DISTANT METASTASIS AND DIFFERENTIAL SURVIVAL BY LENGTH OF ANDROGEN DEPRIVATION THERAPY IN RTOG PROTOCOL 92-02